SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fischer Medical Ventures collaborates with Nanyang Biologics

16 Jul 2024 Evaluate

Fischer Medical Ventures (Fischer MV) has collaborated with Singapore company, Nanyang Biologics (NYB), a leading drug discovery company dedicated to create transformative nutraceuticals derived from natural plants & herbs. This strategic partnership aims to revolutionize healthcare industry by delivering innovative, evidence-based products that enhance overall health and wellbeing, guided by rigorous scientific research and data-driven methodologies. 

Fischer MV is known for its affordable, and accessible medical diagnostic and imaging technologies, by leveraging cutting-edge innovations and AI-powered software solutions in healthcare. As the first company to indigenously manufacture high-quality Magnetic Resonance Imaging (MRI) systems in India and owning a diverse portfolio of breakthrough diagnostic solutions, Fischer MV is moving into preventative healthcare space with NYB.

NYB aims to address the need for streamlined compound discovery, improved drug development efficiency, and targeted solutions for chronic diseases such as cancer and metabolic disorders, and to foster collaboration across sectors to drive innovation and accelerate the translation of research into impactful clinical applications, reducing time and resource burdens, and ultimately improving global healthcare outcomes.

Fischer Medical Ventures is engaged in the trading of certain grades of Laboratory Chemicals.


Fischer Medical Share Price

40.80 0.22 (0.54%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 234.90
Adani Enterprises 2218.35
Amrapali Industries 17.53
Rashi Peripheral 455.25
PDS 301.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×